Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Michigan State University receives $1.8 million NIH grant to improve brain implants

Michigan State University receives $1.8 million NIH grant to improve brain implants

Portable mini microscope could improve scientists' ability to study brain disease in living mice

Portable mini microscope could improve scientists' ability to study brain disease in living mice

Researchers develop new technology to mass produce cerebral cortex neurons

Researchers develop new technology to mass produce cerebral cortex neurons

Scientists untangle the brain's life-support network

Scientists untangle the brain's life-support network

Brain can produce new cells even at the age of 90

Brain can produce new cells even at the age of 90

Symptomatic pharmacotherapy of elderly people should be regularly monitored

Symptomatic pharmacotherapy of elderly people should be regularly monitored

People with untreated diabetes develop signs of Alzheimer's disease at a faster rate

People with untreated diabetes develop signs of Alzheimer's disease at a faster rate

Researchers develop new augmented reality app to assess spatial memory

Researchers develop new augmented reality app to assess spatial memory

States push for caregiver tax credits

States push for caregiver tax credits

Cerveau announces research collaboration agreement with Eisai for novel tau imaging agent

Cerveau announces research collaboration agreement with Eisai for novel tau imaging agent

MSU professor receives NSF CAREER grant for biosensor diagnostics

MSU professor receives NSF CAREER grant for biosensor diagnostics

Exploring pathophysiological factors that link sleep problems and Alzheimer's disease

Exploring pathophysiological factors that link sleep problems and Alzheimer's disease

Using the Mastermind strategy in brain research

Using the Mastermind strategy in brain research

Hidden differences between pathology of CTE and Alzheimer's disease discovered

Hidden differences between pathology of CTE and Alzheimer's disease discovered

Creating diverse pool of trained scientists to address Alzheimer's research needs

Creating diverse pool of trained scientists to address Alzheimer's research needs

Innovative membrane offers a viable solution for periodontitis

Innovative membrane offers a viable solution for periodontitis

Brain area that only processes spoken, not written words identified

Brain area that only processes spoken, not written words identified

A change in focus could enable the development of new treatments for Alzheimer's disease

A change in focus could enable the development of new treatments for Alzheimer's disease

Alzheimer's patients using antiepileptic drugs have twice the risk of pneumonia, study shows

Alzheimer's patients using antiepileptic drugs have twice the risk of pneumonia, study shows

Isolated seniors chat online to prevent cognitive decline

Isolated seniors chat online to prevent cognitive decline

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.